Adaptive upregulation of BCL2 was determined in NAFLD (41), while there was a significant low level of BCL2 and elevated apoptosis in nonalcoholic steatohepatitis (NASH) (42). This evidence concerns the gene BCL2 and metabolic dysfunction-associated steatohepatitis.